BlackRock Inc. (NYSE: BLK) beats Q2-2026 adjusted EPS consensus of approximately $12.54 per share on July 15, 2026
Pending
✦ AI-generated prediction
Published on 12. July 2026
·
Predicted for 15. July 2026
·
Based on: Historical Cycle
BlackRock reports Q2-2026 results on July 15 before market open. Consensus: ~$12.54–12.63 adjusted EPS. Benzinga shows Earnings ESP of +1.21% – a classic upside signal. No dedicated Polymarket/Kalshi market. Drivers: AUM growth from S&P 500 rally above 7,700, revenue est. +24.5% YoY to ~$6.75B. Alternatives strengthened by HPS Investment Partners integration (Jan 2025). BLK historically beats consensus in 4 of 5 quarters.
Data basis for this prediction
- Benzinga, 10.07.2026: 'BlackRock Earnings Imminent; Most Accurate Analysts Revise Forecasts' – Earnings ESP +1,21 %
- Zacks/Yahoo Finance: BLK Q2 2026 EPS Konsens 12,54 USD, revenue +24,5 % YoY auf 6,75 Mrd. USD
- TipRanks: Wall Street consensus 12,63 USD EPS; report date July 15, 2026
- Yahoo Finance BLK Earnings Preview: 'BlackRock Expected to Grow' (Stand Juli 2026)
Note: This is an AI-generated statistical forecast for entertainment and information purposes. It does not constitute investment advice or a recommendation to buy or sell any financial instrument.
Verdict: Pending
This prediction is still open. It will be evaluated automatically against real-world sources after its due date.
📈 Economy
✦ AI
The ONS publishes UK retail sales for June on July 24, 2026. May 2026: +1.2% MoM (+3.2% YoY) – a strong base. The CBI Distributive Trades Survey (June 26, 2026) showed the sharpest annual volume decline in over a year, weakest for the time of year since early 2024; July YoY balance at -45. No Polymarket/Kalshi market. Deloitte commentary notes potential World Cup uplift, but this likely only shows in July data. Inflation, weak June consumer confidence, and the high May base point to a negative MoM reading.
📈 Economy
✦ AI
J&J reports Q2-2026 results on July 15, 2026 before market open. Analyst consensus (Benzinga, TipRanks): ~$2.85 adjusted EPS (vs. $2.77 prior year, +2.9% YoY). J&J has beaten EPS consensus in 20+ consecutive quarters. Benzinga analysis July 11, 2026: 'Likely To Report Higher Q2 Earnings.' No dedicated Polymarket/Kalshi market. Key drivers: pharma (Tremfya, Darzalex, Tecvayli), MedTech recovery. Revenue consensus: ~$25.02B. Historical beat rate >75% supports another upside.
📈 Economy
✦ AI
The Philly Fed MBOS for July 2026 is released on July 16, 2026 at 8:30 AM ET. June 2026 jumped to +10.3 after -0.4 in May – the largest single-month swing in recent memory. Series is highly volatile (±12–20 pts typical). Positives: Iran conflict de-escalation reduces energy fears (ZEW June: +10.5), improved orders component in June. Headwinds: Trump tariffs weigh on input costs. No Polymarket/Kalshi market. Given volatility, a single-month dip below zero is plausible (39% counter-probability).